Please login to the form below

Not currently logged in
Email:
Password:

DTC spending triples in US

A US study has revealed that drug companies now spend 2.6 times 1996 levels on direct-to-consumer (DTC) advertising for drugs in the US.

A US study has revealed that drug companies now spend 2.6 times 1996 levels on direct-to-consumer (DTC) advertising for drugs in the US.

Researchers at the University of Pittsburgh Graduate School of Public Health found that total spending on pharmaceutical promotion increased to USD 29.9bn in 2005 from USD 11.4bn in 1996, or an annual growth rate of 10.6 per cent.

DTC advertising, which began back in 1996, has increased by 330 per cent over the past ten years.

The Pittsburgh team examined industry data from three market-research firms which track advertising spending by the pharmaceutical industry.

Study leader, Julie Donohue said: "Our analysis found that the trend toward increasing spending on direct-to-consumer advertising is likely to continue and efforts to enforce more stringent guidelines on such practices would require not only significant changes by the pharmaceutical industry but by the FDA as well."

2nd September 2008

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. We are an award-winning agency with over 30...

Latest intelligence

Online Physician Communities
Is the pharma industry bad?
Surveys of doctors and the public suggest not...
Salary survey now open - how will you measure up?
Take part for a chance to win a Kindle Fire HD tablet...
Online Physician Communities
M3 and partners win Digital Sales Aid Award
Wins for campaign to overcome limited doctor engagement with pharma-owned websites...